Lineage Cell Therapeutics LCTX
NYSE LCTX
$0.98 +0.03 (+3.16%)
At close: Oct 22, 2026 · 4:00 PM EDT

Lineage Cell Therapeutics (LCTX) Ending Cash Balance (2016 - 2026)

Updated

Analysis

Lineage Cell Therapeutics (LCTX) Ending Cash Balance (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 6.57 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 4.88 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 3.18 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 1.03 Bn
10 Lineage Cell Therapeutics 247.85 Mn 46.25 Mn - 37.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.92 Mn
Mar 31, 2026 36.48 Mn
Dec 31, 2025 41.32 Mn
Sep 30, 2025 40.98 Mn
Jun 30, 2025 42.78 Mn
Mar 31, 2025 48.34 Mn
Dec 31, 2024 46.35 Mn
Sep 30, 2024 28.31 Mn
Jun 30, 2024 30.17 Mn
Mar 31, 2024 44.12 Mn
Dec 31, 2023 35.99 Mn
Sep 30, 2023 32.00 Mn
Jun 30, 2023 34.45 Mn
Mar 31, 2023 16.02 Mn
Dec 31, 2022 11.94 Mn
Sep 30, 2022 25.30 Mn
Jun 30, 2022 71.36 Mn
Mar 31, 2022 78.61 Mn
Dec 31, 2021 56.28 Mn
Sep 30, 2021 61.33 Mn
API Access

Lineage Cell Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=LCTX&period=max&api_key=YOUR_API_KEY